CVS Health Corporation $CVS Shares Bought by Toth Financial Advisory Corp

Toth Financial Advisory Corp increased its stake in CVS Health Corporation (NYSE:CVS) by 16.8% during the 3rd quarter, Holdings Channel.com reports. The fund owned 71,807 shares of the pharmacy operator’s stock after buying an additional 10,352 shares during the period. Toth Financial Advisory Corp’s holdings in CVS Health were worth $5,414,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. HF Advisory Group LLC raised its stake in CVS Health by 2.9% during the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock worth $393,000 after purchasing an additional 145 shares during the period. FineMark National Bank & Trust increased its holdings in shares of CVS Health by 1.7% during the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after buying an additional 157 shares during the last quarter. 1620 Investment Advisors Inc. raised its position in shares of CVS Health by 6.1% in the 3rd quarter. 1620 Investment Advisors Inc. now owns 2,736 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 157 shares during the period. Smartleaf Asset Management LLC grew its position in CVS Health by 1.1% during the second quarter. Smartleaf Asset Management LLC now owns 15,059 shares of the pharmacy operator’s stock valued at $1,031,000 after acquiring an additional 164 shares during the period. Finally, Hazlett Burt & Watson Inc. increased its stake in CVS Health by 10.9% during the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after acquiring an additional 165 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Down 0.1%

NYSE CVS opened at $77.70 on Friday. The stock has a market cap of $98.63 billion, a P/E ratio of 204.47, a PEG ratio of 0.77 and a beta of 0.48. The company’s fifty day simple moving average is $79.09 and its 200-day simple moving average is $72.37. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the business earned $1.09 EPS. The business’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. TD Cowen lifted their price target on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Barclays raised their target price on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Finally, Leerink Partners upped their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.67.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.